"That is very different from a drug actually causing a new cancer." The review emphasizes that for patients with papillary, follicular, or Oncocytic (Hrthle cell) thyroid cancers, current evidence does not support the idea that GLP-1 medications cause these diseases or worsen their course
Frequently asked questions Retatrutide is a once-weekly injection that targets three hormones- GLP-1 , GIP , and glucagon -for appetite control, blood-sugar stability, and fat burning
The Zepbound KwikPen is also available on Ro (if eligible) for a cash price of $299$499 per month, depending on the dose
Indirectly, yes
First, GLP-1 receptor agonists can reduce B12 absorption over time by altering gastric acid secretion
Weight loss: By increasing satiety and reducing food intake, as well as slowing gastric emptying, GLP-1s help reduce body weight (which further helps metabolic health)